Our data show that the serum levels of IgE and TNF-α were suppressed in the patients with IBD and food allergy after the treatment with SIT and CB, indicating that the therapy also blocked mast cell activation since mast cells are one of the major sources of TNF-α in the body [22]. This evidence concerns the gene TNF and inflammatory bowel disease.